SCHEMBL3717049

SCHEMBL3717049

CC(C)c1[nH]nc2c(NCc3cc(O)cc(Cl)c3)nc(NCC(C)(C)N)nc12

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 18/20 0.50
CCNE1 P24864 16/20 0.50
CDK5 Q00535 13/20 0.50
CDK9 P50750 3/20 0.44
CDK5R1 Q15078 3/20 0.44
CCNT1 O60563 2/20 0.44
CDK7 P50613 2/20 0.44
CCNH P51946 1/20 0.44
CDK1 P06493 5/20 0.43
CCNB1 P14635 4/20 0.43
CCNB2 O95067 2/20 0.43
CCNB3 Q8WWL7 2/20 0.43
CDK4 P11802 2/20 0.43
CCNA2 P20248 2/20 0.43
CCND1 P24385 2/20 0.43
CDK6 Q00534 1/20 0.43
AURKA O14965 1/20 0.41
CCNE2 O96020 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3717058 0.84 BCDIN3D (0.35) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL3794926 0.84 CDK2 (0.52) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL3718522 0.79 CDK2 (0.71) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL3717711 0.78 CDK2 (0.53) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL3720115 0.78 CDK2 (0.51) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL3718461 0.75 CDK2 (0.54) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL7260702 0.71 CDK2 (0.52) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL3726416 0.70 CDK2 (0.56) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL3720174 0.69 CDK2 (0.62) CDK2CCNE1CDK5CDK9CDK5R1
SCHEMBL2908697 0.69 CDK2 (0.52) CDK2CCNE1CDK5CDK9CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010139288-A1 5,7-DISUBSTITUTED 3-ISOPROPYLPYRAZOLO[4,3-D]PYRIMIDINES FOR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS C3 BIO GMBH (DE) 2010-12-09 WO disclosed